abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL)

71 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q4 2021.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3.87M shares of 28.9M outstanding shares and own 13.42% of the company stock.
Largest 10 shareholders include NEEDHAM INVESTMENT MANAGEMENT LLC (450K shares), MORGAN STANLEY (380K shares), Advisors Asset Management, Inc. (372K shares), FLAGSHIP HARBOR ADVISORS, LLC (335K shares), WELLS FARGO & COMPANY/MN (302K shares), LPL Financial LLC (208K shares), LAZARD ASSET MANAGEMENT LLC (185K shares), COHEN & STEERS, INC. (126K shares), UBS Group AG (122K shares), and Atlantic Union Bankshares Corp (99.1K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.